• mail us help@statsmarketresearch.com
  • Int'l (+1)-646-781-7170

TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

T-Cell Immunotherapy Market - Global Outlook and Forecast 2021-2027

T-Cell Immunotherapy Market - Global Outlook and Forecast 2021-2027

  • Category:Life Sciences
  • Published on : 13 October 2021
  • Pages :93
  • Formats:
  • Report Code:SMR-6586657
Click for best price

Best Price: $2600

This report contains market size and forecasts of T-Cell Immunotherapy in Global, including the following market information:
Global T-Cell Immunotherapy Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global T-Cell Immunotherapy market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
We surveyed the T-Cell Immunotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T-Cell Immunotherapy Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global T-Cell Immunotherapy Market Segment Percentages, By Type, 2020 (%)
CAR-T
TCR
TIL Therapies

China T-Cell Immunotherapy Market, By Application, 2016-2021, 2022-2027 ($ millions)
China T-Cell Immunotherapy Market Segment Percentages, By Application, 2020 (%)
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others

Global T-Cell Immunotherapy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global T-Cell Immunotherapy Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total T-Cell Immunotherapy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total T-Cell Immunotherapy Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics

TABLE OF CONTENTS

1 Introduction to Research & Analysis Reports
1.1 T-Cell Immunotherapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global T-Cell Immunotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global T-Cell Immunotherapy Overall Market Size
2.1 Global T-Cell Immunotherapy Market Size: 2021 VS 2027
2.2 Global T-Cell Immunotherapy Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top T-Cell Immunotherapy Players in Global Market
3.2 Top Global T-Cell Immunotherapy Companies Ranked by Revenue
3.3 Global T-Cell Immunotherapy Revenue by Companies
3.4 Top 3 and Top 5 T-Cell Immunotherapy Companies in Global Market, by Revenue in 2020
3.5 Global Companies T-Cell Immunotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 T-Cell Immunotherapy Players in Global Market
3.6.1 List of Global Tier 1 T-Cell Immunotherapy Companies
3.6.2 List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global T-Cell Immunotherapy Market Size Markets, 2021 & 2027
4.1.2 CAR-T
4.1.3 TCR
4.1.4 TIL Therapies
4.2 By Type - Global T-Cell Immunotherapy Revenue & Forecasts
4.2.1 By Type - Global T-Cell Immunotherapy Revenue, 2016-2021
4.2.2 By Type - Global T-Cell Immunotherapy Revenue, 2022-2027
4.2.3 By Type - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global T-Cell Immunotherapy Market Size, 2021 & 2027
5.1.2 Stomach Cancer
5.1.3 Lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Esophagus Cancer
5.1.6 Pancreatic Cancer
5.1.7 Others
5.2 By Application - Global T-Cell Immunotherapy Revenue & Forecasts
5.2.1 By Application - Global T-Cell Immunotherapy Revenue, 2016-2021
5.2.2 By Application - Global T-Cell Immunotherapy Revenue, 2022-2027
5.2.3 By Application - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global T-Cell Immunotherapy Market Size, 2021 & 2027
6.2 By Region - Global T-Cell Immunotherapy Revenue & Forecasts
6.2.1 By Region - Global T-Cell Immunotherapy Revenue, 2016-2021
6.2.2 By Region - Global T-Cell Immunotherapy Revenue, 2022-2027
6.2.3 By Region - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America T-Cell Immunotherapy Revenue, 2016-2027
6.3.2 US T-Cell Immunotherapy Market Size, 2016-2027
6.3.3 Canada T-Cell Immunotherapy Market Size, 2016-2027
6.3.4 Mexico T-Cell Immunotherapy Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe T-Cell Immunotherapy Revenue, 2016-2027
6.4.2 Germany T-Cell Immunotherapy Market Size, 2016-2027
6.4.3 France T-Cell Immunotherapy Market Size, 2016-2027
6.4.4 U.K. T-Cell Immunotherapy Market Size, 2016-2027
6.4.5 Italy T-Cell Immunotherapy Market Size, 2016-2027
6.4.6 Russia T-Cell Immunotherapy Market Size, 2016-2027
6.4.7 Nordic Countries T-Cell Immunotherapy Market Size, 2016-2027
6.4.8 Benelux T-Cell Immunotherapy Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia T-Cell Immunotherapy Revenue, 2016-2027
6.5.2 China T-Cell Immunotherapy Market Size, 2016-2027
6.5.3 Japan T-Cell Immunotherapy Market Size, 2016-2027
6.5.4 South Korea T-Cell Immunotherapy Market Size, 2016-2027
6.5.5 Southeast Asia T-Cell Immunotherapy Market Size, 2016-2027
6.5.6 India T-Cell Immunotherapy Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America T-Cell Immunotherapy Revenue, 2016-2027
6.6.2 Brazil T-Cell Immunotherapy Market Size, 2016-2027
6.6.3 Argentina T-Cell Immunotherapy Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa T-Cell Immunotherapy Revenue, 2016-2027
6.7.2 Turkey T-Cell Immunotherapy Market Size, 2016-2027
6.7.3 Israel T-Cell Immunotherapy Market Size, 2016-2027
6.7.4 Saudi Arabia T-Cell Immunotherapy Market Size, 2016-2027
6.7.5 UAE T-Cell Immunotherapy Market Size, 2016-2027
7 Players Profiles
7.1 Adaptimmune
7.1.1 Adaptimmune Corporate Summary
7.1.2 Adaptimmune Business Overview
7.1.3 Adaptimmune T-Cell Immunotherapy Major Product Offerings
7.1.4 Adaptimmune T-Cell Immunotherapy Revenue in Global (2016-2021)
7.1.5 Adaptimmune Key News
7.2 Altor Bioscience Corporation
7.2.1 Altor Bioscience Corporation Corporate Summary
7.2.2 Altor Bioscience Corporation Business Overview
7.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Major Product Offerings
7.2.4 Altor Bioscience Corporation T-Cell Immunotherapy Revenue in Global (2016-2021)
7.2.5 Altor Bioscience Corporation Key News
7.3 Cellectis
7.3.1 Cellectis Corporate Summary
7.3.2 Cellectis Business Overview
7.3.3 Cellectis T-Cell Immunotherapy Major Product Offerings
7.3.4 Cellectis T-Cell Immunotherapy Revenue in Global (2016-2021)
7.3.5 Cellectis Key News
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Corporate Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics T-Cell Immunotherapy Major Product Offerings
7.4.4 Juno Therapeutics T-Cell Immunotherapy Revenue in Global (2016-2021)
7.4.5 Juno Therapeutics Key News
7.5 Kite Pharma
7.5.1 Kite Pharma Corporate Summary
7.5.2 Kite Pharma Business Overview
7.5.3 Kite Pharma T-Cell Immunotherapy Major Product Offerings
7.5.4 Kite Pharma T-Cell Immunotherapy Revenue in Global (2016-2021)
7.5.5 Kite Pharma Key News
7.6 Novartis
7.6.1 Novartis Corporate Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis T-Cell Immunotherapy Major Product Offerings
7.6.4 Novartis T-Cell Immunotherapy Revenue in Global (2016-2021)
7.6.5 Novartis Key News
7.7 Takara Bio
7.7.1 Takara Bio Corporate Summary
7.7.2 Takara Bio Business Overview
7.7.3 Takara Bio T-Cell Immunotherapy Major Product Offerings
7.4.4 Takara Bio T-Cell Immunotherapy Revenue in Global (2016-2021)
7.7.5 Takara Bio Key News
7.8 Unum Therapeutics
7.8.1 Unum Therapeutics Corporate Summary
7.8.2 Unum Therapeutics Business Overview
7.8.3 Unum Therapeutics T-Cell Immunotherapy Major Product Offerings
7.8.4 Unum Therapeutics T-Cell Immunotherapy Revenue in Global (2016-2021)
7.8.5 Unum Therapeutics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. T-Cell Immunotherapy Market Opportunities & Trends in Global Market
Table 2. T-Cell Immunotherapy Market Drivers in Global Market
Table 3. T-Cell Immunotherapy Market Restraints in Global Market
Table 4. Key Players of T-Cell Immunotherapy in Global Market
Table 5. Top T-Cell Immunotherapy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global T-Cell Immunotherapy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global T-Cell Immunotherapy Revenue Share by Companies, 2016-2021
Table 8. Global Companies T-Cell Immunotherapy Product Type
Table 9. List of Global Tier 1 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 T-Cell Immunotherapy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - T-Cell Immunotherapy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region ? Global T-Cell Immunotherapy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global T-Cell Immunotherapy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global T-Cell Immunotherapy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America T-Cell Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe T-Cell Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America T-Cell Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa T-Cell Immunotherapy Revenue, (US$, Mn), 2022-2027
Table 30. Adaptimmune Corporate Summary
Table 31. Adaptimmune T-Cell Immunotherapy Product Offerings
Table 32. Adaptimmune T-Cell Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 33. Altor Bioscience Corporation Corporate Summary
Table 34. Altor Bioscience Corporation T-Cell Immunotherapy Product Offerings
Table 35. Altor Bioscience Corporation T-Cell Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 36. Cellectis Corporate Summary
Table 37. Cellectis T-Cell Immunotherapy Product Offerings
Table 38. Cellectis T-Cell Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 39. Juno Therapeutics Corporate Summary
Table 40. Juno Therapeutics T-Cell Immunotherapy Product Offerings
Table 41. Juno Therapeutics T-Cell Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 42. Kite Pharma Corporate Summary
Table 43. Kite Pharma T-Cell Immunotherapy Product Offerings
Table 44. Kite Pharma T-Cell Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 45. Novartis Corporate Summary
Table 46. Novartis T-Cell Immunotherapy Product Offerings
Table 47. Novartis T-Cell Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 48. Takara Bio Corporate Summary
Table 49. Takara Bio T-Cell Immunotherapy Product Offerings
Table 50. Takara Bio T-Cell Immunotherapy Revenue (US$, Mn), (2016-2021)
Table 51. Unum Therapeutics Corporate Summary
Table 52. Unum Therapeutics T-Cell Immunotherapy Product Offerings
Table 53. Unum Therapeutics T-Cell Immunotherapy Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. T-Cell Immunotherapy Segment by Type
Figure 2. T-Cell Immunotherapy Segment by Application
Figure 3. Global T-Cell Immunotherapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global T-Cell Immunotherapy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global T-Cell Immunotherapy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2020
Figure 8. By Type - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 9. By Application - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 10. By Region - Global T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 11. By Country - North America T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 12. US T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 16. Germany T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 17. France T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 24. China T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 28. India T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 30. Brazil T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa T-Cell Immunotherapy Revenue Market Share, 2016-2027
Figure 33. Turkey T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE T-Cell Immunotherapy Revenue, (US$, Mn), 2016-2027
Figure 37. Adaptimmune T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Altor Bioscience Corporation T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Cellectis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Juno Therapeutics T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Kite Pharma T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Novartis T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Takara Bio T-Cell Immunotherapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

SELECT A FORMAT

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount